| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/05/2010 | US20100196910 Methods of generating human cardiac cells and tissues and uses thereof |
| 08/05/2010 | US20100196909 Parp-based cytochemical and histochemical detection methods and kits therefore |
| 08/05/2010 | US20100196908 Systems and methods for detecting a signal and applying thermal energy to a signal transmission element |
| 08/05/2010 | US20100196907 Markers to predict and monitor response to aurora kinase b inhibitor therapy |
| 08/05/2010 | US20100196906 Accelerated Progression Relapse Test |
| 08/05/2010 | US20100196905 Adult Stem Cell Assays |
| 08/05/2010 | US20100196904 Ambient temperature stable kits for molecular diagnostics |
| 08/05/2010 | US20100196903 Compositions and methods to detect tmprss2/erg transcript variants in prostate cancer |
| 08/05/2010 | US20100196902 Prostate cancer biomarkers |
| 08/05/2010 | US20100196901 Method for Obtaining Information on Biological Rhythm by Using Hair |
| 08/05/2010 | US20100196900 Method of detecting canine exercise-induced collapse |
| 08/05/2010 | US20100196899 Systems for genome selection |
| 08/05/2010 | US20100196898 Disease-associated genetic variations and methods for obtaining and using same |
| 08/05/2010 | US20100196897 Method and Device for Non-Invasive Prenatal Diagnosis |
| 08/05/2010 | US20100196896 Method and a kit for identifying a human who has the predisposition for increased consumption of carbohydrates and method for managing the named human's dietary intake of nutritional energy |
| 08/05/2010 | US20100196895 Method for determination of onset risk of glaucoma |
| 08/05/2010 | US20100196894 Procedure for the detection of paratuberculosis |
| 08/05/2010 | US20100196893 Method for genotyping DNA tandem repeat sequences |
| 08/05/2010 | US20100196892 Methods and Systems for Molecular Fingerprinting |
| 08/05/2010 | US20100196891 IBC-1 (Invasive Breast Cancer-1), a Putative Oncogene Amplified in Breast Cancer |
| 08/05/2010 | US20100196890 Primers for melting analysis |
| 08/05/2010 | US20100196889 Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer |
| 08/05/2010 | US20100196888 Genotyping Using Multiple Variant-Specific Primer Pools |
| 08/05/2010 | US20100196887 Compositions and methods for multiplex analysis of polynucleotides |
| 08/05/2010 | US20100196886 Screening, diagnosing, treating and prognosis of pathophysiologic status by rna regulation |
| 08/05/2010 | US20100196885 Methods of validating candidate compounds for use in treating copd and other diseases |
| 08/05/2010 | US20100196884 Nucleic Acid Preparation |
| 08/05/2010 | US20100196883 Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions |
| 08/05/2010 | US20100196882 GALECTIN-3 nsSNP MARKER FOR CANCER |
| 08/05/2010 | US20100196881 Reverse restriction fragment length polymorphism assay and uses thereof |
| 08/05/2010 | US20100196880 Compositions and multiplex assays for measuring biological mediators of physiological health |
| 08/05/2010 | US20100196879 DNA Diagnostic screening for turner syndrome and sex chromosome disorders |
| 08/05/2010 | US20100196878 Dual-recognition immunoassay for the detection of antibodies |
| 08/05/2010 | US20100196877 Method of detection of microorganisms with enhanced bacteriophage amplification |
| 08/05/2010 | US20100196876 Methods and Reagents for Genotyping HCV |
| 08/05/2010 | US20100196875 Human erythrovirus |
| 08/05/2010 | US20100196874 method of drug design |
| 08/05/2010 | US20100196636 Indicators for detecting the presence of metabolic byproducts from microorganisms |
| 08/05/2010 | US20100196582 Soybeans with reduced isoflavones |
| 08/05/2010 | US20100196524 Novel peptides and methods for producing them |
| 08/05/2010 | US20100196509 Methods for Diagnosis and Treatment of Endometrial Cancer |
| 08/05/2010 | US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 08/05/2010 | US20100196426 Use of microvesicles in diagnosis and prognosis of medical diseases and conditions |
| 08/05/2010 | US20100196420 Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs |
| 08/05/2010 | US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS |
| 08/05/2010 | US20100196410 Streptococcus pneumoniae Antigens and Vaccines |
| 08/05/2010 | US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof |
| 08/05/2010 | US20100196402 Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody |
| 08/05/2010 | US20100196400 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 08/05/2010 | US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions |
| 08/05/2010 | US20100196397 Five-helix protein |
| 08/05/2010 | US20100196383 Connective Tissue Growth Factor (CTGF-3) |
| 08/05/2010 | US20100196382 Nontypeable Haemophilus Influenzae Virulence Factors |
| 08/05/2010 | US20100196375 Engineered scFv against Bovine Herpes Virus Type I |
| 08/05/2010 | US20100196366 Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto |
| 08/05/2010 | US20100196360 Neutrokine-alpha and neutrokine-alpha splice variant |
| 08/05/2010 | US20100196358 Method and kit to profile tumors by biomarker analyses including transcriptional factor assays |
| 08/05/2010 | US20100196357 Microrna modulators and method for identifying and using the same |
| 08/05/2010 | US20100196354 Glutamate receptor antagonists and methods of use |
| 08/05/2010 | US20100196351 Secreted pate-like proteins |
| 08/05/2010 | US20100196349 Reeler domain containing protein |
| 08/05/2010 | US20100196347 Bone grafts with reduced protease activity and methods of selection and use |
| 08/05/2010 | US20100196346 Novel substrate for rpn 11 enzymatic activity |
| 08/05/2010 | US20100196336 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
| 08/05/2010 | US20100196335 Methods and Compositions for Regulated Expressions of Nucleic Acid at Post-Transcriptional Level |
| 08/05/2010 | US20100196327 Methods for diagnosing biological samples containing stem cells |
| 08/05/2010 | US20100196283 Method and imaging medium for use in the method |
| 08/05/2010 | US20100196275 Methods and products for neutralizing the harmful effects of combustion products |
| 08/05/2010 | US20100193355 Novel glucose dehydrogenase and method for producing the dehydrogenase |
| 08/05/2010 | US20100192369 Electrochemical Cell |
| 08/05/2010 | DE102010000906A1 Conjugate, useful in detecting double stranded nucleic acids, comprises an uncharged intercalator, a spacer that is covalently bonded to intercalator, a first and second linker molecule and a detectable marker |
| 08/05/2010 | DE102009046128A1 Non-invasive method for screening of active agent/formulation against skin aging in vivo, comprises contacting human with agent/formulation, applying adhesive tape to skin and tearing off, extracting the biological material and detecting |
| 08/05/2010 | DE102009007381A1 Antibiotische Peptide Antimicrobial peptides |
| 08/05/2010 | DE102008064065B3 Farbstofflösung Dye solution |
| 08/05/2010 | DE102006056694B4 Verfahren zum Durchführen einer enzymatischen Reaktion A method for performing an enzymatic reaction |
| 08/05/2010 | CA2788452A1 Method of making dna tag |
| 08/05/2010 | CA2753971A1 Accelerated progression relapse test |
| 08/05/2010 | CA2751256A1 Methods of categorizing an organism |
| 08/05/2010 | CA2751223A1 Novel cell lines and methods |
| 08/05/2010 | CA2751215A1 Cell lines expressing cftr and methods of using them |
| 08/05/2010 | CA2751213A1 Methods of detecting sepsis |
| 08/05/2010 | CA2751159A1 Cell lines expressing nav and methods of using them |
| 08/05/2010 | CA2751130A1 Production of closed linear dna |
| 08/05/2010 | CA2750979A1 Methylation assay |
| 08/05/2010 | CA2750978A1 Lung cancer methylation markers |
| 08/05/2010 | CA2750922A1 Li-key hybrid peptides that modulate the immune response to influenza |
| 08/05/2010 | CA2750879A1 Adaptors for nucleic acid constructs in transmembrane sequencing |
| 08/05/2010 | CA2750820A1 Thermophilic helicase dependent amplification technology with endpoint homogenous fluorescent detection |
| 08/05/2010 | CA2750576A1 Novel peptides and methods for producing them |
| 08/05/2010 | CA2750338A1 Sequence-specific large volume sample preparation method and assay |
| 08/05/2010 | CA2750029A1 Method for quantification of small rna species |
| 08/05/2010 | CA2749945A1 Markers to predict and monitor response to aurora kinase b inhibitor therapy |
| 08/05/2010 | CA2748228A1 Selection of animals for desired milk and/or tissue profile |
| 08/04/2010 | EP2213752A1 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 08/04/2010 | EP2213751A1 Polymer for detection of target substance, and method for detection of target substance |
| 08/04/2010 | EP2213750A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid |
| 08/04/2010 | EP2213749A1 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders |
| 08/04/2010 | EP2213748A2 Analytical instrument having improved arrangement of reagent section and analytical method |
| 08/04/2010 | EP2213741A2 Compositions and methods of using a synthetic DNAse I |
| 08/04/2010 | EP2213740A1 Human telomerase catalytic subunit |